U.S. flag An official website of the United States government
  1. Home
  2. About FDA
  3. FDA Organization
  4. Office of Medical Products and Tobacco
  5. Center for Drug Evaluation and Research | CDER
  6. Division of Pediatric and Maternal Health
  1. Center for Drug Evaluation and Research | CDER

Division of Pediatric and Maternal Health


The Office of New Drugs is undergoing a reorganization. This site may be updated in the near future. Please check back often. For more information, please visit Reorganization of the Office of New Drugs with Corresponding Changes to the Office of Translational Sciences and the Office of Pharmaceutical Quality.

Division Director: Lynne Yao, M.D.
Deputy Director: John Alexander, M.D., MPH

The Division of Pediatric and Maternal Health (DPMH) is located in the Office of New Drugs.  DPMH oversees quality initiatives which promote and necessitate the study of drug and biological products in the pediatrics, pregnant women, and breastfeeding populations and improve pregnancy and lactation-related information in product labeling.

What is DPMH’s Role?

To collaborate to develop clinically relevant, evidence-based labeling and other communications that facilitate informed use of drugs and biologics in children, pregnant females, lactating females, and females and males of reproductive potential.


Contact DPMH

Food and Drug Administration
Center for Drug Evaluation and Research
Office of New Drugs
10903 New Hampshire Avenue
Silver Spring, MD 20993
Main Line: 301-796-2200   
Fax: 301-796-9744